Mechanism of Endothelial Dysfunction in Apolipoprotein E-Deficient Mice
暂无分享,去创建一个
[1] S. Tokuno,et al. Endothelial dysfunction in atherosclerotic mice: improved relaxation by combined supplementation with L‐arginine‐tetrahydrobiopterin and enhanced vasoconstriction by endothelin , 2000, British journal of pharmacology.
[2] R. Cohen,et al. Decreased sensitivity to nitric oxide in the aorta of severely hypercholesterolemic apolipoprotein E-deficient mice. , 2000, Journal of cardiovascular pharmacology.
[3] C. Mallari,et al. Role of endogenous nitric oxide in progression of atherosclerosis in apolipoprotein E-deficient mice. , 2000, American journal of physiology. Heart and circulatory physiology.
[4] P. Gambert,et al. Impairment of endothelium-dependent arterial relaxation by high-fat feeding in ApoE-deficient mice: toward normalization by human ApoA-I expression. , 1999, Circulation.
[5] F. Faraci,et al. Agonist-specific impairment of coronary vascular function in genetically altered, hyperlipidemic mice. , 1999, American journal of physiology. Regulatory, integrative and comparative physiology.
[6] D. Harrison,et al. Validation of lucigenin as a chemiluminescent probe to monitor vascular superoxide as well as basal vascular nitric oxide production. , 1999, Biochemical and biophysical research communications.
[7] T. Lüscher,et al. Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[8] P. Tsao,et al. Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. , 1998, Circulation.
[9] T. Lüscher,et al. Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis. , 1998, Circulation.
[10] B. Davidson,et al. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. , 1998, Circulation research.
[11] D. Harrison,et al. Vascular expression of extracellular superoxide dismutase in atherosclerosis. , 1998, The Journal of clinical investigation.
[12] J. Zweier,et al. Validation of Lucigenin (Bis-N-methylacridinium) as a Chemilumigenic Probe for Detecting Superoxide Anion Radical Production by Enzymatic and Cellular Systems* , 1998, The Journal of Biological Chemistry.
[13] J. Crapo,et al. Manganic porphyrins possess catalase activity and protect endothelial cells against hydrogen peroxide-mediated injury. , 1997, Archives of biochemistry and biophysics.
[14] D. Heistad,et al. Atherosclerosis, vascular remodeling, and impairment of endothelium-dependent relaxation in genetically altered hyperlipidemic mice. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[15] R. Weisbrod,et al. Reduced responsiveness of hypercholesterolemic rabbit aortic smooth muscle cells to nitric oxide. , 1997, Arteriosclerosis, thrombosis, and vascular biology.
[16] J S Beckman,et al. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. , 1996, The American journal of physiology.
[17] D. Harrison,et al. Nitric oxide regulates vascular cell adhesion molecule 1 gene expression and redox-sensitive transcriptional events in human vascular endothelial cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[18] S. Milstien,et al. Effect of tetrahydrobiopterin on endothelial function in canine middle cerebral arteries. , 1996, Circulation research.
[19] K. Hirata,et al. Endothelial constitutive nitric oxide synthase protein and mRNA increased in rabbit atherosclerotic aorta despite impaired endothelium-dependent vascular relaxation. , 1996, The American journal of pathology.
[20] C. Szabó,et al. Evaluation of the relative contribution of nitric oxide and peroxynitrite to the suppression of mitochondrial respiration in immunostimulated macrophages using a manganese mesoporphyrin superoxide dismutase mimetic and peroxynitrite scavenger , 1996, FEBS letters.
[21] R. Brandes,et al. Supplementation of hypercholesterolaemic rabbits with L-arginine reduces the vascular release of superoxide anions and restores NO production. , 1995, Atherosclerosis.
[22] P. Libby,et al. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. , 1995, The Journal of clinical investigation.
[23] A. Quyyumi,et al. Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis. , 1995, The Journal of clinical investigation.
[24] I. Fridovich,et al. Stable Mn(III) porphyrins mimic superoxide dismutase in vitro and substitute for it in vivo. , 1994, The Journal of biological chemistry.
[25] R. Johns,et al. Inhibition of nitric oxide synthase by a superoxide generating system. , 1993, The Journal of pharmacology and experimental therapeutics.
[26] K. Tornheim,et al. Superoxide anion production by rabbit thoracic aorta: effect of endothelium-derived nitric oxide. , 1993, The American journal of physiology.
[27] D. Harrison,et al. Hypercholesterolemia increases endothelial superoxide anion production. , 1993, The Journal of clinical investigation.
[28] R. Ross. The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.
[29] E. Rubin,et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells , 1992, Cell.
[30] N. Maeda,et al. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. , 1992, Science.
[31] D. Harrison,et al. Chronic treatment with polyethylene-glycolated superoxide dismutase partially restores endothelium-dependent vascular relaxations in cholesterol-fed rabbits. , 1991, Circulation research.
[32] D. Harrison,et al. Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. , 1990, The Journal of clinical investigation.
[33] Paul M. Vanhoutte,et al. The Endothelium: Modulator of Cardiovascular Function , 1990 .
[34] S. Snyder,et al. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[35] S. Moncada,et al. Vascular endothelial cells synthesize nitric oxide from L-arginine , 1988, Nature.
[36] L. Ignarro,et al. Endothelium‐Derived Relaxing Factor From Pulmonary Artery and Vein Possesses Pharmacologic and Chemical Properties Identical to Those of Nitric Oxide Radical , 1987, Circulation research.
[37] S. Moncada,et al. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor , 1987, Nature.
[38] Richard J. Jones. Heart Disease: A Textbook of Cardiovascular Medicine , 1980 .
[39] S. Schwartz,et al. Maintenance of integrity in aortic endothelium. , 1980, Federation proceedings.
[40] J. D. Smith,et al. Mouse models of atherosclerosis. , 1998, Laboratory animal science.
[41] J. Kastelein,et al. Tetrahydrobiopterin restores endothelial function in hypercholesterolemia. , 1997, The Journal of clinical investigation.
[42] T. Lüscher,et al. The Endothelium as a Regulator of Vascular Tone and Growth , 1995 .
[43] D. Harrison. Endothelial dysfunction in atherosclerosis. , 1994, Basic research in cardiology.
[44] L. Ignarro. Biosynthesis and metabolism of endothelium-derived nitric oxide. , 1990, Annual review of pharmacology and toxicology.